Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-23-004572
Filing Date
2023-03-24
Accepted
2023-03-24 16:40:24
Documents
118
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K jagx-20221231x10k.htm   iXBRL 10-K 3367672
2 EX-21.1 jagx-20221231xex21d1.htm EX-21.1 4607
3 EX-23.1 jagx-20221231xex23d1.htm EX-23.1 6973
4 EX-23.2 jagx-20221231xex23d2.htm EX-23.2 5651
5 EX-31.1 jagx-20221231xex31d1.htm EX-31.1 9704
6 EX-31.2 jagx-20221231xex31d2.htm EX-31.2 9954
7 EX-32.1 jagx-20221231xex32d1.htm EX-32.1 5260
8 EX-32.2 jagx-20221231xex32d2.htm EX-32.2 6019
9 GRAPHIC jagx-20221231x10k003.jpg GRAPHIC 52672
10 GRAPHIC jagx-20221231xex23d1001.jpg GRAPHIC 13327
  Complete submission text file 0001558370-23-004572.txt   14401046

Data Files

Seq Description Document Type Size
11 EX-101.SCH jagx-20221231.xsd EX-101.SCH 116717
12 EX-101.CAL jagx-20221231_cal.xml EX-101.CAL 90334
13 EX-101.DEF jagx-20221231_def.xml EX-101.DEF 548928
14 EX-101.LAB jagx-20221231_lab.xml EX-101.LAB 856837
15 EX-101.PRE jagx-20221231_pre.xml EX-101.PRE 741253
112 EXTRACTED XBRL INSTANCE DOCUMENT jagx-20221231x10k_htm.xml XML 2376151
Mailing Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104
Business Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104 415-371-8300
Jaguar Health, Inc. (Filer) CIK: 0001585608 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36714 | Film No.: 23760399
SIC: 2834 Pharmaceutical Preparations